MedTrace Logo

Capsule Endoscopy in Newly Diagnosed Patients of Celiac Disease

NCT03731806 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-08-23

No results posted yet for this study

Summary

Celiac Disease is an autoimmune disorder that affects approximately 1% of the world's population 1. The diagnosis of CD requires clinical, histopathological and serological factors 2. Since upper gastrointestinal endoscopy allows only visualization of the small bowel up to the second part of duodenum therefore this study was designed to determine involvement of different segments of small bowel using endoscopic scale by Bonatto MW et al 3 in newly diagnosed patients of celiac disease.

Conditions

Sponsors & Collaborators

  • Tazeen Rasheed

    lead OTHER

Principal Investigators

  • Bader F Zuberi, FCPS · Dow University of Health Sciences

Eligibility

Min Age
8 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2020-03-31
Completion
2020-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03731806 on ClinicalTrials.gov